Drug Profile
Alpha synuclein SMART molecule - ICB International/CRCHUS
Alternative Names: a-Syn SMART Molecule; a-Syn-SMLatest Information Update: 28 Jul 2021
Price :
$50
*
At a glance
- Originator ICB International
- Developer Centre de recherche du Centre hospitalier universitaire de Sherbrooke; ICB International
- Class Imaging agents; Radiopharmaceutical diagnostics
- Mechanism of Action Positron-emission tomography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Parkinson's disease
Most Recent Events
- 28 Jul 2021 No recent reports of development identified for preclinical development in Parkinson's-disease in USA (Parenteral)
- 28 Jan 2019 No recent reports of development identified for preclinical development in Parkinson's-disease(Diagnosis) in Canada (Parenteral)
- 28 Jan 2019 No recent reports of development identified for preclinical development in Parkinson's-disease(Diagnosis) in USA (Parenteral)